RICOVR Trademark

Trademark Overview

On Sunday, July 7, 2019, a trademark application was filed for RICOVR with the United States Patent and Trademark Office. The USPTO has given the RICOVR trademark a serial number of 88502739. The federal status of this trademark filing is REGISTERED as of Tuesday, June 8, 2021. This trademark is owned by Ricovr Healthcare Inc.. The RICOVR trademark is filed in the Medical Instrument Products category with the following description:

Medical apparatus and units for dosage, measuring and monitoring, namely, drug delivery devices and systems
ricovr

General Information

Serial Number88502739
Word MarkRICOVR
Filing DateSunday, July 7, 2019
Status700 - REGISTERED
Status DateTuesday, June 8, 2021
Registration Number6381026
Registration DateTuesday, June 8, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 5, 2019

Trademark Statements

Pseudo MarkRECOVER
Goods and ServicesMedical apparatus and units for dosage, measuring and monitoring, namely, drug delivery devices and systems

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateMonday, July 15, 2019
Primary Code010
First Use Anywhere DateSaturday, October 21, 2017
First Use In Commerce DateThursday, December 21, 2017

Trademark Owner History

Party NameRicovr Healthcare Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 08542
Party NameRicovr Healthcare Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 08542
Party NameRicovr Healthcare Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 08542

Trademark Events

Event DateEvent Description
Tuesday, June 8, 2021REGISTERED-PRINCIPAL REGISTER
Friday, May 7, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, May 6, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, May 6, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 6, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 6, 2021ASSIGNED TO LIE
Monday, January 25, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, July 24, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, July 24, 2020NON-FINAL ACTION E-MAILED
Friday, July 24, 2020SU - NON-FINAL ACTION - WRITTEN
Friday, July 24, 2020SU - NON-FINAL ACTION - WRITTEN
Friday, July 24, 2020SU - NON-FINAL ACTION - WRITTEN
Thursday, July 9, 2020STATEMENT OF USE PROCESSING COMPLETE
Thursday, June 18, 2020USE AMENDMENT FILED
Thursday, July 9, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, June 18, 2020TEAS STATEMENT OF USE RECEIVED
Tuesday, December 31, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 5, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 5, 2019PUBLISHED FOR OPPOSITION
Wednesday, October 16, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 1, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 24, 2019ASSIGNED TO EXAMINER
Monday, July 15, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, July 10, 2019NEW APPLICATION ENTERED

Related Keywords

ricovr drug delivery devices systems namely monitoring apparatus units dosage measuring